Connect your AI

Perspective Therapeutics CATX Earnings yield

Earnings yield at other companies

Eli LillyLLY

3.1%+1.6pp

CytomX TherapeuticsCTMX

-5.8%-87.5pp

Monopar TherapeuticsMNPR

-4.1%-1.3pp

ImmunomeIMNM

-9.1%-3.9pp

Viridian Therapeutics, Inc.VRDN

-18%-4.7pp

Lantheus HoldingsLNTH

5.7%+1.7pp

Other financials

Income statement

Revenue$2.2M+27.3%

Gross profit$738.0K+78.3%

Operating income-$28.3M-29.5%

Net income-$26.2M-44.1%

EPS (diluted)-$0.250.0%

Balance sheet

Cash & equivalents$54.0M+21.5%

Total debt$4.2M+10.9%

Total equity$347.4M+22.1%

Total assets$410.8M+24.7%

Cash flow

Operating cash flow-$31.5M-45.8%

CapEx$6.9M+47.3%

Free cash flow-$38.3M-46.1%

Valuation

Market cap$342.14M+33.2%

Enterprise value$292.34M+35.2%

P/S34.2×+19.6×

Profitability

Gross margin33.1%-7.1pp

Operating margin-292.7%-553pp

Net margin-218.4%-781pp

FCF margin-1,073.3%—

Returns & leverage

Return on equity-35.2%+2.3pp

Debt / equity0×0.0×

Current ratio8.7×-8.3×

Where this comes from

Calculated from Perspective Therapeutics’s reported figures.

net income/market cap=-23.4%

Based on trailing twelve months.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Perspective Therapeutics's earnings yield?: Perspective Therapeutics (CATX) reported earnings yield of -23.4% in Q1 2026.
How has Perspective Therapeutics's earnings yield changed year-over-year?: Perspective Therapeutics's earnings yield increased by 56.7% year-over-year, from -54% to -23.4%.
What is the long-term trend for Perspective Therapeutics's earnings yield?: Over 5 years (2020 to 2025), Perspective Therapeutics's earnings yield has grown at a 41.6% compound annual growth rate (CAGR), from -8.9% to -50.4%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.